nadolol (Q424952)

nadolol (English)

3 October 2016

CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O

1 reference

nadolol (English)

3 October 2016

CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O

1 reference

https://www.whocc.no/atc_ddd_index/?code=C07AA12

nadolol (English)

3 October 2016

0.16 gram

route of administration

oral administration

1 reference

reference URL

1 reference

15 February 2018

World Health Organisation international non-proprietary name

nadolol (English)

1 reference

Nadolol (English)

medical condition treated

19 January 2016

myocardial infarction

1 reference

13 December 2016

arterial hypertension

1 reference

13 December 2016

congestive heart failure

1 reference

13 December 2016

1 reference

Drug Indications Extracted from FAERS

13 December 2016

1 reference

United States Food and Drug Administration

2 October 2018

arterial hypertension

start time

9 December 1979

approved by

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/FEN504330V

2 November 2018

reference URL

http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018063s063lbl.pdf

significant drug interaction

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivastigmine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methyldopa

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

terazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

doxazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tamsulosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfuzosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

myocardial depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sinoatrial arrest

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

withdrawal hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

decreased heart rate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

shortened atrioventricular conduction time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lidocaine

anxiety

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lidocaine

myocardial depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lidocaine

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

17 August 2016

route of administration

oral administration

0 references

legal status (medicine)

boxed warning

1 reference

reference URL

imported from Wikimedia project

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

US pregnancy category C

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Nadolol

last update

15 January 2017

mass

309.194008 dalton

1 reference

nadolol (English)

3 October 2016

2 references

5 March 2018

15 March 2018

1 reference

MeSH descriptor ID

D009248

15 March 2018

antihypertensive drug

1 reference

15 March 2018

1 reference

15 March 2018

C29280

1 reference

UNII

FEN504330V

InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1

15 February 2018

Identifiers

InChI

1 reference

nadolol (English)

3 October 2016

1 reference

nadolol (English)

3 October 2016

2 references

Nadolol (English)

3 October 2016

15 February 2018

1 reference

Nadolol (English)

3 October 2016

2 references

nadolol (English)

3 October 2016

Reaxys registry number

2508986

0 references

1 reference

Nadolol (English)

19 January 2016

1 reference

NADOLOL (English)

3 October 2016

2 references

inferred from InChIKey

splash10-0udi-0092000000-e09452da687c6073a284

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA001898

0 references

MSBNK-Waters-WA001899

0 references

MSBNK-Waters-WA001900

0 references

MSBNK-Waters-WA001901

0 references

MSBNK-Waters-WA001902

0 references

MSBNK-Waters-WA001903

0 references

SPLASH

0 references

splash10-0uk9-4690000000-81baaf08e07647128956

0 references

splash10-0kmi-4930000000-adbaba8c066f6c5c5558

0 references

splash10-0aba-3900000000-3784678375e682bb5b2f

0 references

splash10-05te-3900000000-52bc796915dc7eb2ff30

0 references

HSDB ID

6532

1 reference

Hazardous Substances Data Bank

28 October 2019

NADOLOL (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

UNII

FEN504330V

ECHA Substance Infocard ID

15 February 2018

100.050.625

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Nadolol (English)

CAS no.: 42200-33-9 (English)

1 reference

Nadolol (English)

publication date

17 November 2015

1 reference

nadolol (English)

3 October 2016

Nadolol

0 references

MeSH tree code

D02.033.100.624.698.601

broader concept

phenoxypropanolamines

0 references

D02.033.755.624.698.601

broader concept

phenoxypropanolamines

0 references

D02.092.063.624.698.601

broader concept

phenoxypropanolamines

0 references

RxNorm CUI

7226

1 reference

15 February 2018

1 reference

Human Metabolome Database ID

HMDB0015334

2 references

based on heuristic

inferred from InChIKey

3 references

Nadolol (English)

3 October 2016

UNII

FEN504330V

15 February 2018

MedlinePlus drug identifier

0 references

1 reference

NADOLOL (English)

19 January 2016

0 references

1 reference

Microsoft Academic ID (discontinued)

Nadolol (English)

19 January 2016

1 reference

28 October 2013

Interlingual Index ID

0 references

1 reference

9 July 2020

2776256041

0 references

NCI Drug Dictionary ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

1 reference

imported from Wikimedia project

German Wikipedia

ScienceDirect topic ID

agricultural-and-biological-sciences/nadolol

0 references

WikiProjectMed ID

Nadolol

0 references

WordNet 3.1 Synset ID

03809851-n

1 reference